Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

Postsurgical Keytruda Has Little Impact on Quality of Life in Melanoma

September 2nd 2024, 7:00pm

Article

Health-related quality of life among patients with stage 3 melanoma was not significantly affected after receiving postsurgical Keytruda or placebo.

Immunotherapy, Academic Centers May Decrease Mortality in Metastatic Cancer

January 17th 2024, 10:00pm

Article

Some with metastatic cancers receiving end-of-life-initiated immunotherapy may have a decreased risk of mortality when treated at a high-volume facility, research found.

FDA Approves Keytruda Plus Chemo for Locally Advanced, Metastatic Biliary Tract Cancer

November 1st 2023, 1:41pm

Article

The Food and Drug Administration approved Keytruda plus chemotherapy for patients with locally advanced unresectable or metastatic biliary tract cancer.

FDA Approves Opdivo for Post-Surgical Stage 2B or 2C Melanoma

October 16th 2023, 1:23pm

Article

The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed

Immunotherapy Shows Promise in Penile Cancer Subset

August 14th 2023, 3:00pm

Article

Certain patients with penile squamous cell carcinoma responded to therapy with an immune checkpoint inhibitor, according to recent research.

Cancer Vaccine Combo a ‘Potential Major Breakthrough’ in Skin Cancer

April 17th 2023, 3:00pm

Article

The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.

The Way of the Future for Treating Early-Stage NSCLC

April 12th 2023, 7:00pm

Article

Treatment for patients with non-small cell lung cancer has evolved to include immunotherapy after surgery and chemotherapy.

Keytruda Plus Chemo May Not Worsen Quality of Life in Subset of Patients With Cervical Cancer

April 7th 2023, 1:00pm

Article

This analysis of the KEYNOTE-826 trial focused on health-related quality of life in patients with persistent, recurrent or metastatic cervical cancer.

Opdivo Before Surgery May Improve 5-Year Survival in NSCLC

April 6th 2023, 3:00pm

Article

Immunotherapy treatment with Opdivo before surgery improved recurrence-free survival and overall survival at five years in patients with non-small cell lung cancer.

Mediterranean Diet May Boost Immunotherapy Outcomes

March 27th 2023, 7:00pm

Article

Patients with advanced melanoma who followed the Mediterranean diet tended to have improved responses to immunotherapy treatment, recent research showed.